Can a blood test change how doctors treat Alzheimer's? new study investigates
NCT ID NCT07099001
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving doctors educational materials about a new blood test for Alzheimer's disease helps them make better care decisions. 178 neurologists and dementia specialists in the US participated in virtual patient cases. The researchers measured changes in diagnosis and treatment recommendations after doctors received the educational materials and test results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that educating doctors about a new blood test improves how they diagnose and manage Alzheimer's disease.
- What could go wrong
- This is a small, completed study using virtual patients, not real ones. The results may not reflect how doctors would act in actual clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
QURE Healthcare
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict chemo brain before it happens?
- A handful of blueberries a day: a new weapon against cognitive decline?
- Can a lifestyle coach lower your risk of stroke and dementia?
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Could a common supplement slow Alzheimer's decline?
- Gene mutation may amplify cognitive risks of brain stimulation in Parkinson's